Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 EV-to-EBITDA is 29.35 as of Aug. 31, 2026, which is 1% below its 10-year median of 29.75. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 515 Healthcare Providers & Services companies, Pramodini Medicare ranks worse than 84.85% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pramodini Medicare's enterprise value is ₹2,644.9 Mil.
Pramodini Medicare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹90.1 Mil. Therefore, Pramodini Medicare's EV-to-EBITDA for today is 29.35.
The historical rank and industry rank for Pramodini Medicare's EV-to-EBITDA or its related term are showing as below:
NSE:PRAMODINI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 29.35 Med: 29.75 Max: 30.14
Current: 29.35
During the past 4 years, the highest EV-to-EBITDA of Pramodini Medicare was 30.14. The lowest was 29.35. And the median was 29.75.
NSE:PRAMODINI's EV-to-EBITDA is ranked worse than 84.85% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.61
vs NSE:PRAMODINI: 29.35
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pramodini Medicare's PE Ratio (TTM) for today is calculated as:
Pramodini Medicare's share price for today is ₹114.80.
Pramodini Medicare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.181.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Pramodini Medicare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare EV-to-EBITDA Chart
Pramodini Medicare Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
EV-to-EBITDA
0.00
0.00
0.00
0.00
Pramodini Medicare Quarterly Data
Mar23
Mar24
Mar25
Dec25
Mar26
EV-to-EBITDA
0.00
0.00
0.00
0.00
0.00
NSE:PRAMODINI vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's EV-to-EBITDA falls into.
Pramodini Medicare's current Enterprise Value is ₹2,644.9 Mil.
Pramodini Medicare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹90.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare (NSE:PRAMODINI) has a EV-to-EBITDA of 29.35 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Pramodini Medicare. This is near median its historical median of 29.75. Over the past decade, Pramodini Medicare's EV-to-EBITDA has ranged from 29.35 to 30.14. According to the industry distribution chart, Pramodini Medicare ranks #437 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 84.9%.
Is Pramodini Medicare's EV-to-EBITDA too high?
Pramodini Medicare's current EV-to-EBITDA of 29.35 is near median its 10-year median of 29.75. Over the past 10 years, this metric has ranged from a low of 29.35 to a high of 30.14. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.61. Pramodini Medicare's value of 29.35 is 176.6% above this industry median. Based on the distribution chart, Pramodini Medicare ranks #437 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #437 out of 515 companies for EV-to-EBITDA. This places Pramodini Medicare in the lower half of its industry. The industry median EV-to-EBITDA is 10.61. Pramodini Medicare's value of 29.35 is 176.6% above this benchmark. Historically, Pramodini Medicare's own EV-to-EBITDA has ranged from 29.35 to 30.14 over the past decade. While the company's 10-year median is 29.75 vs. the industry median of 10.61, Pramodini Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.61, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pramodini Medicare's current EV-to-EBITDA of 29.35 is 176.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Pramodini Medicare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current EV-to-EBITDA is 29.35, which is near median its own 10-year median of 29.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current EV-to-EBITDA of 29.35. The current EV-to-EBITDA is 29.35, which is near median its 10-year median of 29.75 and 176.6% above the Healthcare Providers & Services industry median of 10.61. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current EV-to-EBITDA is 29.35 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
